Report: Top-selling used EVs cost up to $5,000 less than last year
Related Articles
-
Eli Lilly Stock Surges on Demand for Weight-Loss Drugs
Eli Lilly beat earnings expectations for the first quarter and raised its outlook for the year.
-
Eli Lilly Stock Surges as Weight Loss Drugs Continue to Fuel Growth
Eli Lilly shares jumped in early trading Tuesday as the drugmaker reported first-quarter earnings above expectations and raised full year...
-
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
The Food and Drug Administration said supplies of Zepbound and Mounjaro are expected to be limited through the second quarter, for all but one dosage.